CSE Bulletin: Delist - Better Plant Sciences Inc.

The common shares of Better Plant Sciences Inc. will be delisted from the CSE at market close today, May 27, 2025.

Better Plant Sciences is currently suspended. See Bulletin 2024-0121.

_________________________________

Les actions ordinaires de Better Plant Sciences Inc. seront radiées du CSE à la clôture du marché aujourd'hui, le May 27, 2025.

Better Plant Sciences est actuellement suspendu. Voir le Bulletin 2024-0121.

Date : Market Close/Clôture du marchés le 27 mai/May 2025
Symbol(s)/Symbole(s) : PLNT.X

 

If you have any questions or require further information, please contact Listings at (416) 367-7340 or E-mail: Listings@thecse.com.

Pour toute question, pour obtenir de l'information supplémentaire veuillez communiquer avec le service des inscriptions au 416 367-7340 ou par courriel à l'adresse: Listings@thecse.com.

News Provided by Newsfile via QuoteMedia

Better Plant SciencesPLNT.X:CCCSE:PLNT.XPsychedelics Investing
PLNT.X:CC
The Conversation (0)
Numinus Wellness Announces Change of Auditor

Numinus Wellness Announces Change of Auditor

Numinus Wellness Inc. (TSX: NUMI) (OTCQB: NUMIF) ("Numinus" or the "Company"), a mental health care company focused on innovative behavioral health treatments with a focus on safe, evidence-based psychedelic-assisted therapies, announces that Davidson & Company LLP ("Davidson") has resigned as... Keep Reading...
Lobe Sciences Ltd. to Attend the ArcStone-Kingswood Growth Summit 2025 in Toronto

Lobe Sciences Ltd. to Attend the ArcStone-Kingswood Growth Summit 2025 in Toronto

lobe sciences ltd. (CSE: LOBE,OTC:LOBEF) (OTCQB: LOBEF) (FSE: LOBE.F) ("Lobe Sciences" or the "Company") a clinical stage biopharmaceutical company focused on developing products to treat diseases with significant unmet medical needs is pleased to announce its participation in the upcoming... Keep Reading...
Dried mushrooms and capsules aligned on a light surface.

Psychedelics Market Update: H1 2025 in Review

The market for psychedelic drugs is emerging as a strategic investment opportunity in healthcare, with forecasts generally placing its value at around US$6.4 billion in 2025. This burgeoning sector is set for robust, double-digit compound annual growth, significantly driven by North America,... Keep Reading...
Glowing mushrooms with colorful graphs in the background on a dark surface.

US Policy Momentum, Clinical Progress Fueling Psychedelics Market in 2025

When the US Food and Drug Administration (FDA) rejected Lykos Therapeutics’ new drug application for MDMA-assisted therapy last August, the initial disappointment cast a shadow over the psychedelics industry. However, the sector is seeing a resurgence of optimism in 2025 on the back of various... Keep Reading...
AVECHO BIOTECHNOLOGY

Avecho and Sandoz enter Exclusive License and Development Agreement to Commercialise CBD for Insomnia in Australia

Avecho Biotechnology Limited (ASX: AVE) (“Avecho” or the “Company”) today announced it has signed an exclusive ten-year development and licensing agreement with Sandoz Group AG (“Sandoz”) for the commercial rights to Avecho’s Phase III cannabidiol (“CBD”) capsule for insomnia in Australia.... Keep Reading...

Compass Pathways to announce fourth quarter and year-end financial results on February 27th, 2025

Compass management will host a conference call at 8:00 am ET (1:00pm UK) Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, announced today that it will release financial results for the fourth... Keep Reading...

Latest News

More News

Latest Press Releases

Stallion Uranium Commencing Ground Electromagnetic Survey on the Coyote Corridor

Blue Sky Completes Geophysical Survey at Amarillo Grande Uranium Project & Identifies Anomaly at Ivana Gap Target for Drill Testing

Quarterly Activities/Appendix 5B Cash Flow Report

Questcorp and Riverside Update Substantial Drilling Progress at the LA Union Gold and Silver Project with Seven Holes Completed at Four Targets

Related News

Energy Investing

Stallion Uranium Commencing Ground Electromagnetic Survey on the Coyote Corridor

Energy Investing

Blue Sky Completes Geophysical Survey at Amarillo Grande Uranium Project & Identifies Anomaly at Ivana Gap Target for Drill Testing

Base Metals Investing

Quarterly Activities/Appendix 5B Cash Flow Report

Base Metals Investing

Questcorp and Riverside Update Substantial Drilling Progress at the LA Union Gold and Silver Project with Seven Holes Completed at Four Targets

Base Metals Investing

Prismo Reports High Grade Gold along with Silver, Copper and Zinc Mineralization at Ripsey Mine

Battery Metals Investing

Trading Halt

Locksley Achieves Breakthrough in US Antimony Concentrate Tests